Soleo Health Holdings, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Soleo Health Holdings, Inc. - overview
Established
2014
Location
Frisco, TX, US
Primary Industry
Pharmaceuticals
About
Soleo Health Holdings, Inc. , based in the US, specializes in delivering complex specialty pharmacy and infusion therapy services, providing tailored solutions for patients with complex medical conditions. Founded in 2014 and headquartered in Frisco, US, Soleo Health Holdings, Inc. operates in the specialty pharmacy sector focusing on complex medical therapies.
The company was acquired by Court Square and WindRose Health Investors in January 2025 for USD 1. 1 billion from H. I. G.
Capital, marking a significant shift in its operational strategy. Drew Walk leads the company as CEO. Soleo Health specializes in complex specialty pharmacy and infusion therapy services, focusing on high-cost therapies for patients with intricate medical conditions. The company provides personalized patient experiences by ensuring access to specialty medications and therapies delivered at home, in provider offices, or through its infusion centers across the US.
Their service range includes therapy management for conditions like generalized myasthenia gravis, bleeding disorders, and various neurological disorders, catering to patients, healthcare providers, pharmaceutical manufacturers, and payors in critical US markets. Soleo Health generates revenue through partnerships with pharmaceutical manufacturers, health systems, payors, and direct patient engagement requiring specialty medications. Their flagship product, IMAAVY™ (nipocalimab-aahu), reflects their focus on specialized therapies. The revenue model is structured around service agreements that streamline patient referrals and management, allowing healthcare providers to concentrate on patient care while Soleo handles medication logistics.
With the recent acquisition finalized in January 2025, Soleo Health Holdings, Inc. plans to expand its specialty pharmacy and infusion services globally. This strategic move is intended to enhance its capabilities and reach in the specialty pharmacy sector. The company is actively developing new products to strengthen its service offerings and intends to penetrate new geographic markets as part of its growth strategy.
Current Investors
H.I.G. Capital
Primary Industry
Pharmaceuticals
Sub Industries
Home Healthcare, Nursing Homes & Assisted Living, Specialty Pharmaceuticals
Website
www.soleohealth.com
Verticals
Mobile Apps
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Soleo Health Holdings, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Soleo Health Holdings, Inc. | - | ||||||||
| Buyout | Completed | Soleo Health Holdings, Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.